Dynamic changes in peripheral blood lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in metastatic osteosarcoma - Top-Institutions - MDSpire

Dynamic changes in peripheral blood lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in metastatic osteosarcoma

By
Longqing Li
Jinlei Liu
Yuan Zhao
Songtao Pang
Bin Zhang
Jia Wen
Yongkui Liu
Yi Zhang
Yan Zhang
Jiazhen Li
Nan Zhou
Xinchang Lu
May 13, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan
Key Differentiators
- Oncology
#2

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Oncology
#3

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
#4

Center for Cancer Immune Therapy, Herlev Hospital

Herlev, Copenhagen
Key Differentiators
- Oncology
#5

Herlev and Gentofte Hospital

Herlev, Copenhagen
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Immunology

Dynamic changes in peripheral blood lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in metastatic osteosarcoma

by Longqing Li, Jinlei Liu, Yuan Zhao, Songtao Pang, Bin Zhang, Jia Wen, Yongkui Liu, Yi Zhang, Yan Zhang, Jiazhen Li, Nan Zhou, Xinchang Lu
May 13, 2026

Related Content

Frontiers In Oncology

Potential targets for boron transport in boron neutron capture therapy

by Yucai Wei, Weijing Zhu, Qian Chen, Huda Alnufaei, Yumin Li, Kate Ricketts
May 28, 2026

Frontiers In Oncology

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

May 28, 2026

Jama Network Open

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors